Pharmacodynamics of Remifentanil Blunting Responses to Tracheal Intubation Performed under Peopofol Anesthesia Administered by TCI in Patients with Myasthenia Gravis

石好,左明章,孟小燕,闫春伶,杨宁

DOI: https://doi.org/10.3760/cma.j.issn.0254-1416.2009.02.006

2009-01-01

Abstract:Objective To investigate the pharmacodynamies of remifentanil blunting the responses to tracheal intubation performed under propofol anesthesia in patients with myasthenia gravis. Methods Forty-five ASA Ⅰ or Ⅱ patients with myasthenia gravis aged 18-64 yr weighing 45-95 kg scheduled for trans-stemal thymectomy were enrolled in this study. ECG, BP, HR, SpO2 and BIS were monitored. Anesthesia was induced with propofol and remifentanil both administered by TCI. The target plasma concentration (Cp) of propofol was set at 4 μg/ml during induction. The initial target effect-site concentration (Ce) of remifentanil was set at 1.8 ng/ml and was increased step by step to 2.7, 4.0 and 6.0 ng/ml until the patients could tolerate laryngoscopy and insertion of larynx unesthetic tube into subglottic space without body movement, coughing or bucking. Topical anesthesia of trachea was then performed by spraying 2% lidocaine 2 ml through the larynx anesthetic tube. Laryngoscope and larynx anesthetic tube were removed and the patients were ventilated with O2 through anesthetic mask for 1-2 min before tracheal intubation. The Ce50 and Ce95 (95% confidence interval) were calculated by Probit analysis. Results The Ce50 and Ce95 of remifentanil blunting responses to tracheal intubation performed with propofol administered by TCI was 2.2 ng/ml (95% CI 2.0-2.3 ng/ml) and 3.0 ng/ml (95% CI 2.8-3.5 ng/ml) respectively.Conclusion The Ce50 and Ce95 of remifentanil blunting responses to tracheal intubation performed under propofol anesthesia are 2.2 and 3.0 ng/ml respectively.